OLWILL SHANE (Chief Development Officer) sold 89.2% of their position (38.40K shares) of PALVELLA THERAPEUTICS, INC. on the open market
Open‑market sale worth $196.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/1/2021ACC: 0001562180-21-005712
Officer· Chief Development Officer
Since Aug 2021
-38.40K
Net shares
Net seller
$196.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
38.40K acquired · 76.80K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+38.40K
Price / share
$1.52
Trade value
$58.37K
% of position
827.9%
8/30/2021
4.64K→43.04K
Common Stock
Direct
Shares
−9.20K
Price / share
$5.00
Trade value
$46K
% of position
21.4%
8/30/2021
43.04K→33.84K
Common Stock
Direct
Shares
−29.20K
Price / share
$5.15
Trade value
$150.38K
% of position
86.3%
8/30/2021
33.84K→4.64K
Total
Net shares
+0.00
Net value
-$138.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/30/2021 | M · Option Exercise | +38.40K | $1.52 | $58.37K | 827.9% | 4.64K | 43.04K |
| Common Stock Direct | 8/30/2021 | S · Sale | −9.20K | $5.00 | $46K | 21.4% | 43.04K | 33.84K |
| Common Stock Direct | 8/30/2021 | S · Sale | −29.20K | $5.15 | $150.38K | 86.3% | 33.84K | 4.64K |
| Total | +0.00 | -$138.01K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
100K shares
Shares
−38.40K
Strike price
1.52
Held after
61.60K
Exercisable
—
8/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock100K shares | 8/30/2021 | M · Option Exercise | −38.40K | 1.52 | — | 61.60K |